$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺是什么时候上市的?
2025-10-19 11:44:20
Check Details
恩杂鲁胺治疗前列腺癌治疗效果怎么样?
2025-10-19 11:44:20
Check Details
阿比特龙医保能报销吗?
2025-10-19 11:44:20
Check Details
恩杂鲁胺大概多久会耐药呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺价格与规格
2025-10-19 11:44:20
Check Details
阿比特龙失效后该怎么办呢?
2025-10-19 11:44:20
Check Details
泽珂售价多少?
2025-10-19 11:44:20
Check Details
恩杂鲁胺主治什么?
2025-10-19 11:44:20
Check Details
恩杂鲁胺中文版的说明书
2025-10-19 11:44:20
Check Details
泽珂要吃多久呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺适应症是什么呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺适用于什么病症呢?
2025-10-19 11:44:20
Check Details
1
2
...
1345
1346
1347
1348
1349
1350
1351
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
3
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
4
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
5
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
6
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
7
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
8
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
9
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
10
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
11
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
12
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring